Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.

Zeidler M, Kleer CG.

J Mol Histol. 2006 Sep;37(5-7):219-23. Epub 2006 Jul 20. Review.

PMID:
16855786
3.

Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements.

Tonini T, D'Andrilli G, Fucito A, Gaspa L, Bagella L.

J Cell Physiol. 2008 Feb;214(2):295-300. Review.

PMID:
17786943
4.

[Recent advances on EZH2 in malignant tumors].

Li J, Fan QH.

Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):856-8. Review. Chinese. No abstract available.

PMID:
20193471
5.

Epigenetic control of hematopoietic stem cell aging the case of Ezh2.

De Haan G, Gerrits A.

Ann N Y Acad Sci. 2007 Jun;1106:233-9. Epub 2007 Mar 1. Review.

PMID:
17332078
6.

Molecular prostate cancer pathology: current issues and achievements.

Schalken JA, Bergh A, Bono A, Foster C, Gospadarowicz M, Isaacs WB, Rubin M, Schröder F, Tribukait B, Tsukamotot T, Wiklund P.

Scand J Urol Nephrol Suppl. 2005 May;(216):82-93. Review.

PMID:
16019760
7.

[Molecular aspects of prostate cancer: recent data from the literature].

Camparo P, Vieillefond A.

Bull Cancer. 2007 Jul;94(7 Suppl):F77-88. Review. French.

PMID:
17845997
8.

Posttranscription regulation of prostate cancer growth.

Shen L, Pili R.

Cancer J. 2008 Jan-Feb;14(1):46-53. doi: 10.1097/PPO.0b013e318162108a. Review.

PMID:
18303483
9.

Imaging gene expression in single living cells.

Shav-Tal Y, Singer RH, Darzacq X.

Nat Rev Mol Cell Biol. 2004 Oct;5(10):855-61. Review.

Supplemental Content

Support Center